It's not hard to commercialise a blood test in the US,...

It's not hard to commercialise a blood test in the US, regulations for tests are fairly loose, as per the CLIA lab pathway setup. I could start selling one tomorrow if I could find a lab to commercialise my test... think Elizabeth Holmes's Theranos! I'd say that Bescreened is similarly dodgy, poor uptake, not recognised by the US medical community, virtually unheard of, no evidence of substantial clinical trials etc.

Australia on the other hand is tightly regulated, as demonstrated by the current TGA bureaucracy red tape and hoops. The Rhythm clinical trial 7 will have been stringently organised for sure. We here in Australia are the ones with 'stellar' standards.

Glen Gilbert expressly stated in an interview that the likes of Roche, Abbott, Siemens, Beckman Coulter are interested. They don't seem like backyard operators to me.

In my opinion Rhythm have been extremely forthcoming with information for investors. The Bescreened team in the US however have virtually no data, interviews, announcements available. As I said earlier I can only find a handful of references to their product online, unlike Rhythm which has thousands.